Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() Avra, Inc. Announces 2022 Expansion, Plans Rapid Expansion Of Clinics In USBy: Avra, Inc. Following a successful merger, Avra currently operating "Springs Rejuvenation" "Locating the right location, with our target demographics is one of the keys to our success," stated a Company source. "To aid us in this effort, we have signed a national representation agreement with Carr Realty Advisors. Carr specializes in locating offices for healthcare." About Springs Rejuvenation Inc. At Springs Rejuvenation we strive to be at the cutting edge of regenerative medicine and anti-aging research. Our mission is to provide patients with individualized, state-of-the- With the goal of addressing the root cause of your pain, rather than just masking it. We want to help you achieve whole body health and rejuvenation. This which will help you feel stronger, improve mood, look younger, heal faster and perform at the optimal level. Our patients have found both freedom from pain and improved quality of life. Our professional staff is uniquely composed of physicians/researchers in the Stem Cell, Anti-Aging research and regenerative medicine, also including sports-related injuries and chronic joint pain. Our Medical Director & Founder is Dr. Charles A. Pereyra , the founder of Springs Rejuvenation Stem Cell Therapy in Atlanta, GA (since 2018). He is our current lead clinical Physician and an expert in Stem Cell, Anti-Aging research and Regenerative medicine. Dr. Juan Pablo Nieto specializes in sports-related injuries as well as chronic joint pain. He has expertise experience with diagnostic ultrasound exams as well as joint and tendon injections with PRP, & prolotherapy. His highlights include caring/treating professional athletes: NBA Wizards & D1 level athletes from different multiple sports and presented research at national conferences. For more information go to: https://springsrejuvenation.com/ FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. End
|
|